Varex Imaging Corp

Varex Imaging Corp(VREX)股票分析

$18.410

-0.009 (-0.05%)收盤時

Loading chart…
最高
18.430
開盤
18.420
成交量加權均價
18.41
成交量
1.18M
市值
597.31M
最低
18.400
成交金額
21.73M
企業價值/稅息折舊攤銷前利潤(TTM)
8.47

Varex Imaging Corporation is a designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.

AI 分析 of Varex Imaging Corp (VREX)

持有

Varex Imaging Corp (VREX) is currently trading at $18.41, which is below the acquisition price of $18.90 per share offered by Teledyne Technologies. The stock has shown a significant year-to-date increase of 58.03%, but the RSI is at 41.048, indicating it is nearing oversold territory. The main risk is the recent downgrade by Sidoti, which could signal potential volatility as the acquisition progresses.

分析師評級(3)

-7.66% 下跌空間
買進
2 買進
0 持有
1 賣出
目前: 18.41
最低
16.00
平均
17.00
最高
18.00

Sidoti

2026-08-10

目標價

$19

中性

B. Riley

2026-02-12

目標價

$18

買進

B. Riley

2025-08-08

目標價

$16

買進

B. Riley

2025-05-13

目標價

$12

買進

B. Riley

2025-05-12

目標價

$12

買進

估值指標

Varex Imaging Corp(VREX)目前預期本益比為 20.28,5 年平均預期本益比為 19.85。

預期本益比

合理
5 年均值 P/E
19.85
目前P/E
20.28
高估
26.65
低估
13.05

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.45
目前EV/EBITDA
8.47
高估
40.01
低估
-11.12

預期股價營收比

合理
5 年均值 P/S
0.79
目前P/S
0.87
高估
1.03
低估
0.56

Alphio AI 對 VREX 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%VREX

$7.77

情境價格

基

基準

基準 · 50%VREX

$6.73

情境價格

悲

悲觀

悲觀 · 25%VREX

$5.95

情境價格

持有 VREX 的大戶

R

Rice Hall James & Associates, LLC

+ 持有VREX

+1.11%

3個月報酬率

事件時間軸

2026-08-10 (ET)

17:00:00

Stocks Open Lower as Middle East Uncertainty Grows

16:30:00

Oppenheimer Downgrades Varex Imaging to Perform

12:30:00

Major Averages Mixed at Open Amid Middle East Uncertainty

11:30:00

B. Riley Downgrades Varex Imaging to Neutral, Price Target $18.90

07:00:00

Teledyne Technologies to Acquire Varex Imaging for $18.90 per Share

資訊

VREX 常見問題 —— 由 Alphio AI 解答

Varex Imaging Corporation is a designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals. It operates in the Healthcare sector (ELECTRONIC COMPONENTS, NEC industry).

Varex Imaging Corp (VREX) is currently trading at $18.41, which is below the acquisition price of $18.90 per share offered by Teledyne Technologies. The stock has shown a significant year-to-date increase of 58.03%, but the RSI is at 41.048, indicating it is nearing oversold territory. The main risk is the recent downgrade by Sidoti, which could signal potential volatility as the acquisition progresses.

3 analysts cover VREX: 2 rate it Buy, 0 Hold and 1 Sell. The average price target is 17.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易